Making an Impact

Founded more than 40 years ago, Glenmark Pharmaceuticals is a global pharmaceutical company with a remarkable track record of achievement and improving patients’ lives with access to affordable medicines. Established in 2012 Glenmark Pharmaceuticals Canada Inc. as a wholly owned subsidiary of Glenmark Holding S.A. in Switzerland, which is part of the global parent company Glenmark Pharmaceuticals Limited based in Mumbai, India and quickly emerged as one of the fastest growing generic organizations in Canada.

Glenmark has the stability, resources, and talent to work on solving serious medical problems, all while doing the right thing for patients, people, and communities.

Today we have a diverse business. As a global leader in generics, we are leveraging our industry expertise and success to fuel extensive research to expand development in specialty branded products and innovative products that are intended to have a major impact on how people live.

Innovation

Our scientific and commercial goals are grounded in the expertise of an elite team of industry veterans. We are determined to innovate: to question accepted wisdom, create new ideas, offer new approaches and never rest on our laurels. We are self-starters who reimagine creative solutions for patients’ and doctors’ needs. We work passionately to retain the entrepreneurial spirit that created Glenmark more than 40 years ago.